Home | About Us | Contact Us | My.JHMI.edu | |||||||||
|
|||||||||
JHM Sites | News & Communications |
Around Campus |
Information Technology |
Health, Safety & Security |
Patient Care |
Human Resources |
Policies | Research & Education |
|
New Johns Hopkins Medicine Leaders Announced for the National Capital Region by the Kimmel Comprehensive Cancer Center at Johns Hopkins
It is with great pleasure and enthusiasm that we announce two important appointments for the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins and for Johns Hopkins Medicine. Irene Gage, M.D., has been appointed assistant professor of radiation oncology and oncology and the regional medical director of oncology for the Johns Hopkins National Capital Region (NCR). Michael Carducci, M.D., Aegon Professor of Oncology, has been appointed the regional research director of oncology for the NCR. Many of you will remember Dr. Gage, who went to medical school at Boston University and completed fellowship training in radiation oncology at Harvard Medical School. She served on the Johns Hopkins University School of Medicine full-time faculty from 1994 to 1998 in Radiation Oncology. After leaving the full-time faculty, Dr. Gage held part-time faculty appointments in Oncology and Radiation Oncology from 1998 to 2006. She led the oncology practice at Sibley Memorial Hospital, as the chief of service and chairman of radiation oncology, from 1999 to 2010, and is both well known and well respected by the medical community in the region. Dr. Gage is charged with strategic development of cancer clinical programming, building upon the stellar services already offered at both Suburban and Sibley. She will set the stage for the growth of an elite cancer program in the D.C. metropolitan area that delivers state-of-the-art cancer care, innovates in the development of cancer treatments, and participates in the training of future leaders in cancer medicine and research. As the regional medical director, Dr. Gage has been charged with quality and safety leadership, as well as strategy development related to expansion and growth of clinical programming. This will be accomplished in collaboration with current and future medical staff in oncology and radiation oncology at both Sibley Memorial Hospital and Suburban Hospital, and by building a JHM oncology network in the region to support the JHM mission. Dr. Carducci, who has been on the JHU School of Medicine faculty since 1995, is currently the director of the SKCCC Prostate Cancer Research Program. He has agreed to lead the development of exciting and unique opportunities to expand the SKCCC research efforts and scope in collaboration with the National Cancer Institute (NCI) in the NCR. These activities take advantage of the geographic adjacency of Suburban Hospital in Bethesda to the NCI, enabling the SKCCC and the NCI access to a multidisciplinary clinical practice to serve as the basis for future clinical research collaborations with the NCI clinician scientists. The goal of this developing relationship is to open innovative clinical trials and increase access to distinctive trials in the region for the local population. Infrastructure to support bio-specimen and image-intensive clinical and translational research will be developed in collaboration with the NCI, bringing together the significant talents and resources of Johns Hopkins Medicine and the NCI. The addition of Suburban and Sibley Memorial Hospitals opens the door to programming in the NCR, which we consider to be a significant opportunity for patients, the community, and Johns Hopkins Medicine. We intend to develop signature oncology programming, congruent with the JHM mission, and to serve the NCR population by bringing the convenience of SKCCC quality and innovation much closer. Please help us support the activities of Drs. Gage and Carducci as they build and expand opportunities for all of us. William G. Nelson, M.D., Ph.D.
Theodore DeWeese, M.D.
Brian Gragnolati
Robert L. Sloan
|